Pharmacology of drugs used to treat osteoarthritis in veterinary practice

Inflammopharmacology

Volumn 11, Issue 4-6, 2003, Pages 385-399

  Lees, Peter ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Dog; Horse; NSAIDs; Osteoarthritis; Pain; PK PD modeling; Ruminants

Indexed keywords

3 AMINO 1 (3 TRIFLUOROMETHYLPHENYL) 2 PYRAZOLINE; 3 METHYLAMINO 1 [3 (TRIFLUOROMETHYL)PHENYL] 2 PYRAZOLINE; ARACHIDONATE 5 LIPOXYGENASE; ARYLPROPIONIC ACID DERIVATIVE; BETAMETHASONE; CARPROFEN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DERACOXIB; DEXAMETHASONE; FLUNIXIN; GLYCOSAMINOGLYCAN POLYSULFATE; HYALURONIC ACID; KETOPROFEN; LICOFELONE; MECLOFENAMIC ACID; MELOXICAM; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOSAN POLYSULFATE; PHENYLBUTAZONE; PREDNISOLONE; PROSTAGLANDIN SYNTHASE; TEPOXALIN; TOLFENAMIC ACID; TRIAMCINOLONE; UNCLASSIFIED DRUG; VEDAPROFEN;

BOVIDS; CARTILAGE; CAT; CONFERENCE PAPER; DOG; DOSE CALCULATION; DRUG MECHANISM; DRUG METABOLISM; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; HORSE; INFLAMMATION; LONG TERM CARE; MAINTENANCE THERAPY; MODEL; NONHUMAN; NUTRIENT; OSTEOARTHRITIS; PAIN; PHARMACODYNAMICS; PRIORITY JOURNAL; SPECIES COMPARISON; ULCER; VETERINARY MEDICINE;

EID: 0842284221     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856003322699564     Document Type: Conference Paper

References (45)

1. Arifah, K. A., et al. (2003). Pharmacodynamics, chiral pharmacokinetics and PK-PD modeling of ketoprofen in the goat, J. Vet. Pharmacol. Ther. 26, 139-150.
2. Arifah, K. A. and Lees, P. (2002). Pharmacodynamics and pharmacokinetics of phenylbutazone in calves, J. Vet. Pharmacol. Ther. 25, 299-309.
3. Arifah, K. A., et al. (2001). Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep, Am. J. Vet. Res. 62, 77-86.
4. 2 from equine chondrocytes and cartilage explants, Am. J. Vet. Res. 60, 98-104.
5. Armstrong, S. and Lees, P. (2002). Effects of carprofen (R and S enantiomers and racemate) on the production of IL-1, IL-6 and TNF-α by equine chondrocytes and synoviocytes, J. Vet. Pharmacol. Ther. 25, 145-153.
6. Benton, H. P., et al. (1997). Effect of carprofen on sulfated glycosaminoglycan metabolism, protein synthesis, and prostaglandin release by cultured osteoarthritic canine chondrocytes, Am. J. Vet. Res. 58, 286-292.
7. Brideau, C. and Van Staden, C. (2001). In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs and cats, Am. J. Vet. Res. 62, 1755-1760.
8. Bryant, C. E., et al. (2003). Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B, Am. J. Vet. Res. 64, 211-215.
9. Flecknell, P. A. and Waterman-Pearson, A. (2000). Pain management in animals. W.B. Saunders, London.
10. 2 production by cultured equine synoviocytes, Am. J. Vet. Res. 61, 499-505.
11. Frean, S. P., et al. (1999). In vitro stimulation of equine articular cartilage proteoglycan synthesis by hyaluronan and carprofen, Res. Vet. Sci. 67, 181-188.
12. Frean, S. P., et al. (2000). Influence of interleukin-1β and hyaluronan on proteoglycan release from equine navicular hyaline cartilage and fibrocartilage, J. Vet. Pharmacol. Ther. 23, 67-72.
13. Frean, S. P., et al. (2002). Effects of anti-arthritic drugs on proteoglycan synthesis by equine cartilage, J. Vet. Pharmacol. Ther. 25, 289-298.
14. Frisbie, D. D., et al. (1997). Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model, Equine Vet. J. 29, 349-359.
15. Giraudel, J. M., et al. (2003). Development and application of in vitro assays for the evaluation of inhibitors of constitutive and inducible cyclooxygenase, J. Vet. Pharmacol. Ther. 26 (Suppl. 1), 173-174.
16. Higgins, A. J., et al. (1984). Tissue-cage model for the collection of inflammatory exudate in ponies, Res. Vet. Sci. 36, 284-289.
17. Higgins, A. J., et al. (1987a). Studies on the use of a novel non-steroidal anti-inflammatory drug in the horse, Equine Vet. J. 19, 60-66.
18. Higgins, A. J., et al. (1987b). Actions of BW 540C in an equine model of acute inflammation: a preliminary study, Vet. Q. 9, 103-110.
19. Holton, L. L., et al. (1998). Comparison of three methods used for assessment of pain in dogs, J. Am. Vet. Med. Ass. 212, 61-66.
20. Landoni, M. F., et al. (1995a). Pharmacokinetics and pharmacodynamics of ketoprofen in calves applying PK/PD modeling, J. Vet. Pharmacol. Ther. 18, 315-324.
21. Landoni, M. F., et al. (1995b). Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/ pharmacodynamic modeling, Am. J. Vet. Res. 56, 786-793.
22. Landoni, M. F., et al. (1996). Pharmacokinetics and pharmacodynamics of tolfenamic acid in calves, Res. Vet. Sci. 61, 26-32.
23. Landoni, M. F. and Lees, P. (1995a). Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modeling, Equine Vet. J. 27, 247-256.
24. Landoni, M. F. and Lees, P. (1995b). Pharmacokinetics and pharmacodynamics of ketoprofen enantiomers in calves, Chirality 7, 586-597.
25. Landoni, M. F., et al. (1999). Enantiospecific pharmacokinetics and pharmacodynamics of ketoprofen in sheep, J. Vet. Pharmacol. Ther. 22, 349-359.
26. Lees, P., et al. (1988a). In vitro and in vivo studies on the binding of phenylbutazone and related drugs to equine feeds and digesta, Res. Vet. Sci. 44, 50-56.
27. Lees, P., et al. (1988b). Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration, Res. Vet. Sci. 44, 57-67.
28. Lees, P., et al. (1999). Pharmacology and therapeutics of joint diseases. Cont. Prof. Dev. Vet. Med. 2, 18-26.
29. Lees, P., et al. (1999). A pharmacodynamic and pharmacokinetics study with vedaprofen in an equine model of acute nonimmune inflammation, J. Vet. Pharmacol. Ther. 22, 96-106.
30. th EAVPT International Congress, J. Vet. Pharmacol. Ther. (Suppl).
31. Lees, P., et al. (2002). Pharmacodynamics and enantioselective pharmacokinetics of racemic carprofen in the horse, J. Vet. Pharmacol. Ther. 25, 433-448.
32. Lipscomb, V. J., et al. (2002). Clinical efficacy and pharmacokinetics of carprofen in the treatment of dogs with osteoarthritis, Vet. Rec. 150, 684-689.
33. Maitho, T. E., et al. (1986). Absorption and pharmacokinetics of phenylbutazone in Welsh Mountain ponies, J. Vet. Pharmacol. Ther. 9, 26-39.
34. Millis, D. L., et al. (2002). Effect of Deracoxib, a New COX-2 inhibitor, on the prevention of lameness induced by chemical synovitis in dogs, Vet. Ther. 3, 453-464.
35. Pelletier, J. P., et al. (2000). Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis, J. Rheum. 27, 2893-2902.
36. Sidhu, P., et al. (2003). Tissue chamber model of acute inflammation in farm animal species, Res. Vet. Sci. 74, 67-77.
37. Soraci, A., et al. (1995). Enantioselective glucuronidation and subsequent biliary excretion of carprofen in horses, Am. J. Vet. Res. 56, 358-361.
38. Streppa, H. K., et al. (2002). Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood, Am. J. Vet. Res. 63, 91-94.
39. Toutain, P. L. (2003). Pharmacokinetics/pharmacodynamics integration in dosage regimen optimization for veterinary medicine, J. Vet. Pharmacol. Ther. 26 (Suppl. 1), 1-8.
40. Toutain, P. L., et al. (1994). Plasma concentrations and therapeutic efficacy of phenylbutazone and flunixin meglumine in the horse: pharmacokinetic/pharmacodynamic modeling, J. Vet. Pharmacol. Ther. 17, 459-469.
41. Toutain, P. L., et al. (2001a). Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog, J. Vet. Pharmacol. Ther. 24, 35-42.
42. Toutain, P. L., et al. (2001b). A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog, J. Vet. Pharmacol. Ther. 24, 43-55.
43. Wallace, J. L., et al. (1998). Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity, Gastroenterology 115, 101-109.
44. Warner, T. D., et al. (1999). Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis, Proc. Natl. Acad. Sci. USA 96, 7563-7568.
45. Welsh, J. C. M., et al. (1992). Influence of feeding schedule on the absorption of orally administered flunixin in the horse, Equine Vet. J. (Suppl.) 11, 62-65.